You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動 | 甘李藥業漲7% 專項國採中標 門冬胰島素最低報價19.98元
格隆匯 11-26 13:50
格隆匯11月26日丨甘李藥業(603087.SH)午後拉昇,現漲7.2%,報76.42元,總市值429億元。據市場消息,胰島素專項國採的餐時胰島素類似物組的競價中,四家企業均中標,其中甘李藥業門冬胰島素注射液3ml:300 單位(筆芯)規格報價為19.98元;門冬胰島素本次集採限價72元/支。在基礎胰島素類似物組的競價中,四家企業均中標甘李藥業甘精胰島素注射液3ml:300 單位(筆芯) 規格報價為48.71元;甘精胰島素本次集採限價132元/支。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account